TPB (TPB) holder plans Rule 144 sale of 140,140 shares on NYSE

Rhea-AI Filing Summary

A holder of TPB common stock has filed a notice of proposed sale under Rule 144. The filing covers the potential sale of 140,140 shares of common stock through J.P. Morgan Securities LLC on the NYSE, with an indicated aggregate market value of $14,131,717 and with 19,070,757 shares outstanding for the issuer. The shares to be sold were originally acquired from the issuer as compensation in multiple grants between 2016 and 2025.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
common stock	J.P. Morgan Securities LLC 270 Park Avenue - 10th Floor New York NY 10017	140140	14131717	19070757	12/08/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
common stock	05/13/2016	Compensation	Issuer			1000	05/13/2016	N/A
common stock	09/05/2017	Compensation	Issuer			41727	09/05/2017	N/A
common stock	04/30/2020	Compensation	Issuer			1000	04/30/2020	N/A
common stock	03/08/2021	Compensation	Issuer			32333	03/08/2021	N/A
common stock	10/28/2021	Compensation	Issuer			500	10/28/2021	N/A
common stock	10/28/2021	Compensation	Issuer			500	10/28/2021	N/A
common stock	02/07/2022	Compensation	Issuer			6092	02/07/2022	N/A
common stock	02/10/2023	Compensation	Issuer			7862	02/10/2023	N/A
common stock	05/15/2023	Compensation	Issuer			1000	05/15/2023	N/A
common stock	02/05/2024	Compensation	Issuer			6524	02/05/2024	N/A
common stock	03/05/2024	Compensation	Issuer			6121	03/05/2024	N/A
common stock	04/01/2024	Compensation	Issuer			6936	04/01/2024	N/A
common stock	08/05/2024	Compensation	Issuer			2822	08/05/2024	N/A
common stock	01/01/2025	Compensation	Issuer			598	01/01/2025	N/A
common stock	03/03/2025	Compensation	Issuer			25125	03/03/2025	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does TPB's latest Form 144 filing disclose?

The Form 144 filing discloses a proposed sale of 140,140 shares of TPB common stock on the NYSE through J.P. Morgan Securities LLC, with an aggregate market value of $14,131,717.

How many TPB shares are outstanding according to this Form 144?

The notice states that the issuer has 19,070,757 shares of common stock outstanding. This figure provides context for the size of the proposed 140,140-share sale.

How were the TPB shares in this Form 144 originally acquired?

The shares listed for potential sale were acquired from the issuer as compensation in multiple transactions between 2016 and 2025, with each line item showing grant dates, amounts, and that the issuer was the source.

Which broker is handling the potential TPB share sale under Rule 144?

The filing identifies J.P. Morgan Securities LLC, located at 270 Park Avenue, 10th Floor, New York, NY 10017, as the broker for the proposed 140,140-share sale of TPB common stock on the NYSE.

When is the approximate date of sale for the TPB shares in this Form 144?

The notice lists an approximate sale date of 12/08/2025 for the proposed sale of 140,140 shares of TPB common stock on the NYSE.

What representation does the selling person make in TPB's Form 144 notice?

The person for whose account the securities are to be sold represents that they do not know any material adverse information about the issuer’s current or prospective operations that has not been publicly disclosed.